Scientists led by Dr Jason Heaney from Baylor College of Medicine in Texas, USA, have found that a failure in the development of sperm cells can lead to the formation of testicular tumours in mice. These findings, published in the journal Development, provide new clues for understanding how testicular cancer arises in mammals.
Testicular cancer is the most common type of cancer to affect men between the ages of 15 and 49, and around 95% of these cases are caused by testicular germ cell tumours. Although testicular germ cell tumours typically manifest after puberty, problems in the embryonic development of germ cells can transform them into cancer cells that form tumours later in life.
In the embryo, germ cells initially have the potential to form many different cell types, a characteristic called pluripotency. Normally, germ cells lose this ability as embryonic development progresses and they become restricted to only form sex cells – sperm in males and eggs in females – in a process known as sex determination. Male sex determination also coincides with the embryonic period when the cancer cells that form testicular germ cell tumours can develop.
As Dr Jason Heaney, Associate Professor at the Department of Molecular and Human Genetics at Baylor College of Medicine revealed, the timing between cancer cell formation and sex determination is more than just coincidental: “previous work from our lab and others indicated that defects in this sex-specific switch may play a central role in facilitating the initiation of testicular germ cell tumours. In this study, we set out to test whether testicular germ cell tumours arise from germ cells that do not begin the sex-specific differentiation process and retain features of pluripotent cells.”
To test this hypothesis, Dr Heaney together with Dr Nicholas Webster and team explored whether a gene called Nanos2, which is needed for sex-determination, also prevented embryonic cancer cells developing in mice. “NANOS2 plays a key role in the sex-specific development of embryonic germ cells by suppressing the female (egg) fate and promoting the male (sperm) fate,” explained Dr Heaney.
Using a strain of mice that spontaneously develop germ cell tumours, the researchers showed that some germ cells lacked NANOS2. Not only did the NANOS2-deficient germ cells fail to mature into sperm, but they remained pluripotent and, crucially, were more likely to transform into embryonic cancer cells. The scientists also characterised the NANOS2-deficient germ cells and uncovered important changes in cell behaviour, which could be used to identify and treat cancer cells in the future. “Our work reveals changes in gene expression when germ cells transform into cancer cells that suggest alterations in metabolism and cell division, which could be used for targeted therapies,” said Dr Heaney.
Although it is currently unclear what role NANOS2 plays in the development of human testicular germ cell tumours, this study highlights an important link to the process of male sex determination, providing a new direction for future research. “Our studies provide functional evidence for a mechanism – disrupted male germ cell fate determination – through which these genes cause testicular germ cell tumours in humans,” said Dr Heaney, “future studies will use genetically modified mice to explore how genes associated with germ cell tumours in humans influence germ cell transformation.”
This press release was released by Development (paper link).
The placenta forms the interface between the maternal and foetal circulatory systems. As well as ensuring essential nutrients, endocrine and immunological signals get through to the foetus to support its development and growth, the placenta must also protect it from the accumulation of potentially toxic compounds. A study from Cécile Demarez, Mariana Astiz and colleagues at the University of Lübeck in Germany now reveals that the activity of a crucial placental gatekeeper in mice is regulated by the circadian clock, changing during the day-night cycle. The study, which has implications for the timing of maternal drug regimens, is published in the journal Development.
Immunofluorescence reveals that the ABCB1 protein (in green) localises to the labyrinth zone of the mouse placenta.
The circadian clock translates time-of-day information into physiological signals through rhythmic regulation of downstream genes. In this study, the researchers discover that in the labyrinth zone of the mouse placenta, a tissue functionally equivalent to the human chorionic villi, clock genes are expressed in a 24h rhythm. Importantly, they show that this placental clock is responsible for regulating the expression and activity of ABCB1, a drug efflux transporter with hundreds of known substrates.
An important prediction of this work is that the time-of-day of maternal treatment could be an important factor to consider to avoid non-desirable effects for the foetus during pregnancy.
“Pharmacological treatments are mostly avoided by pregnant women but in certain circumstances there is no other option,” says Dr. Mariana Astiz. “An example would be maternal treatment with antiretrovirals (many of which are in fact substrates of ABCB1). So, choosing the correct time of day to take drugs like these might reduce the ammount of drug reaching the baby and hence the possible negative effects in the short and long-term.”
Dr. Astiz hopes this study will provide a stimulus to design studies that specifically test hypotheses about the placental circadian clock in humans. “This is definitely a very exciting and rapidly advancing field of research.”
When I wrote the #DevBiolWriteClub rules, I made Rule #2 simply restate Rule #1. This, of course, was a cheap ploy by the author to make the reader compare him favorably to Brad Pitt. But there is a serious intent behind it.
Becoming a better writer takes dedication and it takes hard work, but mainly it takes patience. Let’s imagine you read my first post on the Node last Spring, or that you’ve been allowing me to hector you on Twitter. By now, you’ve put a year of effort into developing your craft as a writer. Seen any impact yet? Perhaps you’ve got more words down on the page, or maybe you’re a bit more pleased with your writing. Maybe, but it’s more likely that any progress you’ve made is pretty much intangible at this point. That’s the nature of writing, and it’s a major part of why it is such a frustrating endeavor.
But trust me, simply practicing is by far the best thing you can do for your writing. If you have an active project, try to write at least a little every day. If you are between writing projects, read more and take the time to notice the writing while you read it. That said, there’s no question that we all hit a wall sometimes. Learning to get some outside help is critical.
Thus, we finally come to Rule #5: You can’t do it alone.
Now, getting help can take two forms. The simpler way is to read books about writing. Notice that I said “books,” plural. I wrote about this in my last post, so I won’t repeat it here, except to say there are LOTS of great books about writing. Go read them. But also know that no book will ever do for you what an engaged reader can do, so let’s talk about the real meat of Rule #5. Show your work to others and get their feedback.
Many years ago, Frank Conlon sent me a great essay in The New Yorker by Atul Gawande. The essay pointed out that essentially all professional athletes will be coached throughout their entire careers, as will most opera singers. But surgeons aren’t. Scientists aren’t, either. So, you need to nurture your own stable of informal coaches.
It turns out that I am both lazy and ambitious. It’s an odd combination but it has made me very good at asking for help. In terms of writing, getting help started early. One of my first “coaches” was Mr. Mike Cullinan, an English teacher loved and feared by generations of students at my high school in Houston. He once gave me a 10 on a paper. Out of 100, yes. You see, he graded content and writing separately and averaged the scores. Various transgressions of grammar or diction had fixed point values (25 points for each run-on sentence). So, despite a high score for content, I had scored a negative 75 for writing. I had to re-write it. I had to re-write most things I wrote for him. And you know what? The writing always got better. Every single time.
By the time I became a PI, I had become religious about seeking advice on anything I write. I actually got the first R01 grant I applied for as a PI. (It was fun to briefly boast of my 100% NIH success rate, but the euphoria was short-lived; I didn’t get the second one.) What’s important to understand, though, is that I spent an entire year writing that grant. Of course, I also had to order equipment, hire people, and go to new faculty orientation. But I worked on the grant, bit by bit, most days. For a year. I revised and revised and revised. Along the way, that one grant application took in the serious feedback of five faculty members, three developmental biologists (Richard Harland, Paul, Krieg, David Parichy) and two cell biologists (Terry O’Halloran, Arturo De Lozzane). It was an awesome learning experience and it generated one of the tightest pieces of grant writing I’ve ever produced.
As I have aged, I find myself more lazy than ambitious, and I sometimes submit writing that no one else has read. It almost always goes badly. Luckily, however, old habits die hard, and I still usually seek input from an outside reader. I wrote an essay in Developmental Cell in 2019. that is probably my favorite piece of writing. But let me tell you, it started poorly. I sent an early draft to Lila Solnica-Krezel, and her response was something like, “Oh, you can’t possibly think of publishing this! It’s awful!” She was absolutely correct. You see, I knew what I wanted to say. It was clear in my head. But the points were wholly lost on my reader. Clearly, I was not yet able to say what I wanted to say. I went back to work, started almost entirely from scratch. It was over a year before I completed the essay and sent it off. Then, I was lucky enough to have Marie Bao handle the essay as Editor at Dev. Cell. She liked the idea and found it important, but the essay needed work. Entire sections had to be cut, other shad to be focused, still others expanded. We went back and forth through several rounds of revision. When the piece was finally published, I was proud of it and I was even more delighted that it was well-received. But honestly, it was a team effort.
I tell this story because it illustrates perhaps the most important and most challenging part of getting feedback on your writing. You have to do it early. The key mistake I see writers make is to wait until the very final stages to get feedback. They want to give their reader a “polished draft,” usually because they are concerned about what the reader will think of their rough work. This presents a host of problems:
First, by the time you’re in the final stages, there is often very little time to make serious revisions. Edits of spelling and grammar, sure; but real change? If you read a friend’s grant that is due in 48 hours and your thought is that all of Aim 1 sucks, what do you do? You correct the typos and perhaps utter a small prayer. You certainly don’t say “replace all of Aim 1.” But what if you had seen that grant three weeks before it was due? Now, it’s true that papers do not come with deadlines, but let’s be honest: Every piece of writing has an expiration date, as the author’s patience with the project inevitably wanes.
Second, by the time you have gotten to what you consider is a polished draft, you obviously like it! And, simply because of the cumulative effect of effort, the more work you put into a piece of writing, the more invested you become. This creates a fatal problem: the longer you wait for feedback, the less you will be willing to change, the less likely you will be to really listen to feedback.
Finally, a more subtle point. If you wait until the end of the process, you will get editorial feedback, but you’ll learn nothing about your craft as a writer. This is especially important for trainees showing their work to mentors. Given the greater experience, your mentor is very likely the better writer. Thus, by sharing your very rough work early in the process, you can get feedback not just on what you’ve written, but also on your writing process. And remember, like it or not, you are a writer, and you need to be serious about getting better at your craft.
So that’s it. Toughen up and show your writing, however rough or embarrassing, to other people and get their feedback. It’s uncomfortable, but it really, really works.
The Beddington Medal is the British Society for Developmental Biology’s major commendation to promising young biologists, awarded for the best PhD thesis in Developmental Biology defended in the year previous to the award.
The design of the medal, mice on a stylised DNA helix, is from artwork by Rosa herself.
In 2020 the Beddington Medal was awarded to Wajid Jawaid, who did his PhD with Berthold Göttgens and Jenny Nichols at the Wellcome-MRC Stem Cell Institute, University of Cambridge. After the cancellation of the spring meeting in 2020, Wajid is going to present his work today at the BSDB/Genetics Society 2021 meeting, right before the 2021 winner (who we’ll also interview soon). In advance, we caught up with Wajid to find out more about his life in science. Be sure to also check out the profile of Wajid – including words from Jenny Nichols and a list of Wajid’s selected publications – over on the BSDB site.
Where were you born and where did you grow up?
Birmingham is my home town and where I was born and schooled. My family are still there and I love visiting regularly.
When did you first get interested in science?
I’ve always been interested in how things work since as far back as I can remember and have had a keen interest in science since school. My eyes were really opened during my first year at University in Aberdeen when I found the treasure trove ‘Pubmed’ during a special study module on road traffic accidents. I couldn’t believe the amount of information that was freely available to anyone with an internet connection.
You came into your PhD from paediatric surgery – why did you decide to move into research, and why with Berthold Göttgens and Jenny Nichols in particular?
I became interested in paediatric surgery after my elective at British Columbia Children’s Hospital in Vancouver which exposed me to rare congenital anomalies and their surgical correction or at least amelioration. The process of reading and learning about the embryology that forms the basis of normal development and how it can go wrong consolidated my interest and I decided I wanted to become a Paediatric surgeon.
My interest in science and embryology drove me to apply for an Academic Clinical Fellowship (ACF) post in Paediatric Surgery based at Alder Hey hospital. There I met two wonderful mentors Professor Paul Losty and Mr Edwin Jesudason. As part of my ACF I visited Dr Emma Rawlin’s lab at the Gurdon Institute. This was my first exposure to lab based research and I soon became aware of the importance of integrating multiple and large sources of data. At the time I also became aware of Professor Jenny Nichol’s work in early embryogenesis, embryonic stem cells and pluripotency.
The Wellcome Trust kindly agreed to allow me to extend my PhD by taking 1 year to do a MPhil in Computational Biology at the Department of Applied Mathematics and Theoretical Physics co-ordinated by Dr Stephen Eglen and Dr Boris Adryan. This was a critical year that gave me the skills that I would use through-out my PhD. During the MPhil I attended a talk given by Professor Bertie Gottgens where he presented his most recent dataset and the concept of computational reconstruction of a pseudo-time developmental trajectory from single cell resolved qPCR data. I approached him and together we developed a project with Professor Jenny Nichols.
Tell us about your PhD project: what were the main questions you were trying to answer?
The development of new technologies allowing application of ‘-omics’ methods to single- cells was paving the way to understanding cell biology at much higher resolutions than previously possible. One application was in elucidating the journey of a progenitor cell as it became sequentially fate restricted until it finally reached its destination cell type. Despite the advances in technology it had not been possible to follow this journey across all genes/transcripts over time in-vivo. Single cell RNA sequencing was in its infancy but had the potential to achieve computational reconstructions of these journeys if single cells could be harvested from mouse embryos and retain their transcriptome. At the time it was not clear whether single cell transcriptomic data could be gathered at sufficient precision from dissociated embryos to allow cell type identification and lineage reconstruction.
The overarching theme of this body of work was to develop methods to reconstruct ordered ontogenic trajectories through sequentially sampled cross-sectional data at gastrulation in mice. The main focus was using single-cell resolved, transcriptomic data collected during early mouse embryonic development. Where available this was supplemented with limited, hand selected cell surface proteomic measurements.
The main aims were: 1. Identify cell populations; 2. Trace biologically plausible trajectories; 3. Identify novel molecular pathways; and 4. Develop models that can faithfully simulate cell progression along trajectories
This method of lineage reconstruction best fitted with retrospective lineage tracing. Lineages were traced based on the assumption that within a window of developmental time, cells with the most similar transcriptional signatures were related by lineage.
And what do you think your key discoveries were?
Our first experiment was to take early mouse embryos at gastrulation at four time points between E6.5 and E7.75. In the 3 later time-points cells were sorted to select for Flk1+ or CD41+ mesodermal cells using and An early key finding was that single cell resolved embryonic cell type could be accurately determined. Having identified cell types we were able to the identify sub-populations within the endothelial cluster and focus our analysis on a set of genes associated with erythromyeloid progenitors. In this way we were able to identify the activation of the leukotriene branch of the arachidonic acid pathway within this subset of endothelium. This reminded me of biochemistry from my pre-clinical years and its association with asthma so I was easily able to recall an inhibitor Zileuton. We went on to validate its role in haematopoiesis in an in vitro model of haematopoiesis. Another interesting observation Zileuton itself a derivative of hydroxyurea induces foetal haemaglobin and may have a role in the treatment of sickle cella anaemia. This finding then potentially suggests the mechanism of action of Zileuton.
Given advances in stem cells and organoids, what do mice still have to tell us about early mammalian development?
There have been great achievements in stem cell biology and organoids but they are still a long way off the gold standard the developing embryo which can at relatively high efficiency develop from a single cell to a recognisable organism with cells arranged in functional organ units. This complex process can not yet be faithfully recapitulated in any stem cell or organoid system.
By studying this process in nature we may be able to adjust our culture systems to improve the fidelity of both stem cell and organoid models of normal physiology and disease.
If you took one abiding memory with you from your PhD, what would it be?
Progress through a PhD is full of ups and downs. The moment that I am most fond of is when I was developing a neural network to model a bifurcating developmental trajectory to endothelial and blood fates. This had worked very well compared to a linear regression model. To test it, I wanted to perform a gene knock-out in Tal 1 which should have resulted in failure in erythroid generation. Unfortunately this was not working and I was ready to change tact when I realised I was dealing with qPCR data where activation was associated with a low cycle count – in my case it meant for knockout I should have been using a value of 14 rather than zero. When I corrected this error the network finally reproduced the experimental findings.
What are you doing post-PhD?
At the moment I have focused on completing clinical training. In the meantime I am also preparing to apply for a post-doc clinical fellowship to combine clinical and research work. My aim in the long term is to combine both research and clinical work. Clinical work often raises questions and challenges providing important research questions.
Where do you think developmental and stem cell biology will be in ten years?
I hope we will capture more the complex interactions and higher order abstractions of these interactions beyond pathways, linking the genome and its structure to function and anatomy. In 10 years, I hope that we are at the stage where our understanding of the information in the genome and the functional modules is sufficient to not only describe how organs develop but also how we can make changes to the programs of development to prevent disease phenotypes. So that in time, rather than disrupting development we can generate our own programs de novo.
Integration of multi-omics data with spatial context may help us move from the concept of differentiating a stem cell to more committed fates to generating complex structures of multiple cell types that can be used as substitutes for organs without artificial or de-cellularised scaffolds. Some organoid systems are already taking an early step in this direction.
When you’re not in the lab, what do you do for fun?
Over the last few years through my children going to a football club, I have become a volunteer coach at this local football club. More recently I’ve got my self a motorbike which I love to ride and fix up.
In the latest episode of Genetics Unzipped we’re finding out how researchers are unlocking the information hidden within the human genome using new technologies like CRISPR gene editing and artificial intelligence with the aim of developing better medicines and getting them faster to the patients who need them.
If you enjoy the show, please do rate and review on Apple podcasts and help to spread the word on social media. And you can always send feedback and suggestions for future episodes and guests to podcast@geneticsunzipped.com Follow us on Twitter – @geneticsunzip
Recently we reported the unexpected ability of fish mutants to develop limb-like bones in their pectoral fins (Hawkins et al., 2021). However, the most critical element of the study—finding these mutants in the first place—receives relatively little attention in the paper. Here I describe our efforts to find these monsters lurking inside the unassuming zebrafish.
The nuts and bolts of fins and limbs
The transition from fins to limbs is a defining transformation in vertebrate history and has served as a pivotal study system for comparative anatomy, paleontology, biomechanics, and developmental biology (Clack, 2009). Insight from each of these fields has illuminated different facets of how a relatively simple ancestral fin evolved into the complex arms and legs of tetrapods. Modern fins and limbs look quite different from one another but revealed in the fossil record are intermediate forms that connect their disparate morphologies (Jessen, 1972; Shubin et al., 2006; Zhu and Yu, 2009). By comparing the gene programs active in fins and limbs, we can ask which patterning mechanisms are common to both appendages, which mechanisms are derived in each, and which could be responsible for the changes in form found in evolution.
Tetrapod limbs have many long bones that articulate end on end away from the shoulder with distinct regions such as the upper arm (humerus), forearm (radius and ulna), and hand (Figure 1). In contrast, the pectoral fins of teleost fishes have just four long bones set side by side (proximal radials) followed distally by some small nodular bones (distal radials) and the dermal fin rays (Arratia, 1999). Non-teleost ray-finned fishes such as the bowfin have a slightly more impressive endoskeleton with additional articulations in the posterior part of the fin. Paleontological evidence suggests that the common ancestor of ray-finned fishes and tetrapods had a pectoral configuration much like that of the bowfin (Jessen, 1972, Zhu and Yu, 2009). In this scenario, teleosts such as the zebrafish represent a reduction of the ancestral appendage skeleton, while limbs exhibit its impressive elaboration (Coates, 1995).
Figure 1. Pectoral appendage anatomy is variable across the bony fishes. From the ancestral configuration that exhibited moderate elaboration in the posterior fin (bottom), teleosts (left) simplified the endoskeleton such that it consists of a row of proximal radials followed by small nodular distal radials. In contrast, in the lineage leading to tetrapods (right), the fin was elaborated through the addition of distal long bones to form a limb with a three-part structure containing the upper arm (humerus), forearm (radius and ulna), and hand (wrist and digits). Anterior to left, distal to top in skeletal schematics.
Forming an impressive body of work spanning the last four decades, developmental geneticists across the globe have discovered and characterized the manifold genes and pathways that control the growth and patterning in the nascent limb, leading to a deep understanding of the signaling ligands, receptors, and transcription factors necessary to make a normal appendage (Capdevila and Izpisúa Belmonte, 2001). Surprisingly, despite the morphological differences, many of these key limb patterning pathways are also expressed in developing teleost fins and play analogous (or conserved) functional roles (Mercader, 2007). There are differences in the expression and signaling function of some of these important players, but on the whole fin buds and limb buds behave quite like one another, and there is not one clear genetic factor present in limbs and absent in fins that is sufficient to imbue ‘limb-ness.’
Fishing for fin mutants
While assessing the role of candidate limb genes in growing fins has yielded critical insights into fin development, my colleagues Katrin Henke, Matthew Harris, and I decided to investigate the genes that can modify the zebrafish fin pattern using forward genetics. In a forward genetics approach, mutations are made at random and the investigator screens through mutated animals to pick out individuals with an interesting phenotype (Patton and Zon, 2001). Once an interesting mutant is found, we then work backwards using genetic mapping to determine which gene was mutated to cause the phenotype. The beauty of forward screens is that they let the organism tell you which genes are important to the process you want to know about. Sometimes you find an allele of a known essential regulator that has been extensively characterized, other times you find a gene that hasn’t been studied at all.
Katrin conducted several prodigious screens with a focus on mutants that affect the formation of the adult skeleton, and isolated hundreds of novel mutants (Henke et al., 2017). One mutant she picked out because of its modified pigmentation and dysmorphic fin rays was of particular interest to me and Matthew. Upon observing the internal skeleton under the dissecting scope, Matthew saw that the fin endoskeleton was affected and suggested I take a look. Shockingly, instead of having just the four long bones set side by side, this mutant had additional long bones forming in the distal endoskeleton that articulated with the proximal elements with a joint analogous to an elbow (Figure 2). This mutant didn’t just have fins, but what it had were not quite limbs either: it grew “flimbs.” At the time my dissertation project was focused on craniofacial mutants, but after this discovery (and Katrin’s blessing) my focus shifted to this fascinating mutant with limb-like fins. All good mutants need a name, and my friend and Old Testament scholar Maria suggested rephaim, a race of biblical giants fabled to have extra digits on their hands and feet.
Figure 2. Novel long bones form in the distal endoskeleton of rephaim mutants. Top panels show the external appearance of wild-type and rephaim mutant fish. Middle panels contain micrographs of pectoral fins stained red for bone and blue for cartilage. The proximal radials are numbered 1 through 4, and the new bones in the mutant are indicated with an asterisk. Bottom panel schematizes the endoskeletons of wild-type and rephaim fins and indicates the position of the intermediate radials and novel joint in the rephaim mutant.
After receiving a name, mutants need to be mapped to determine which gene is affected. Genetic mapping of mutations used to be a long and involved process using chromosomal markers to track linkage and recombination. In early zebrafish screens, a mutant line would be crossed to a wild-type fish from a different genetic background, and PCR-based methods would be used to find variable genomic positions and track down regions of DNA that segregated with the mutant phenotype (Knapik et al., 1996). In the last 15 years, however, the advent of next-generation sequencing made it possible to sequence mutants and their wild-type siblings to quickly identify genomic regions that associate with the mutant phenotype. To map rephaim, we utilized a whole-exome mapping approach to determine genomic regions that likely contain the causative mutation (Bowen et al., 2012). The mapping data gave us two putative regions that could contain the rephaim mutation, one on chromosome 4 and one on chromosome 9. Chromosome 4 has a reputation as being a nightmare for mapping, replete with inversions and transposons, and the implicated interval didn’t contain any interesting limb patterning genes. I did not like chromosome 4. On the other hand, the interval on chromosome 9 contained the HoxD cluster, a battery of genes with critical roles in appendage patterning and particularly implicated in the differential patterning of fins and limbs (Sordino et al., 1995; Freitas et al., 2012; Woltering et al., 2014). Not only would a mutation in a HoxD gene fit my expectations of what could cause a phenotype like rephaim, it would make subsequent analysis of the mutant phenotype much easier and fit well within the existing fin-to-limb literature. I even thought I might finish my dissertation early.
This, however, was not to be. Linkage analysis definitively ruled out chromosome 9 and the HoxD cluster. The initial mapping signal that I had pinned my hopes on was due to a block of genetic homogeneity that was shared between mutants and wild-type siblings, meaning that both mutants and wild-type animals had the same alleles in this region and thus could not contain the causative mutation. Meanwhile, additional recombination analysis strengthened the association of rephaim with chromosome 4 and narrowed the linkage interval to a small window containing just one coding mutation in a gene called wiskott-aldrich syndrome protein like-b (waslb). Unlike my precious HoxD cluster, the waslb gene was not a known regulator of limb development, and everything I saw in the literature gave the impression that it was a “housekeeping” gene: ubiquitous expression, essential functions in actin metabolism, and involvement in myriad cellular pathways (Snapper and Rosen, 1999). Around this time, we were also mapping a second mutant with a similar phenotype, a fish called wanda (van Eeden et al., 1996; Haffter et al., 1996). The causative mutation for wanda mapped to the gene vav2, a similarly unexciting locus from a skeletal patterning perspective (Hornstein et al., 2004). I felt the path to my PhD lengthening in real time.
X marks the spot on a genetic treasure map
Nevertheless, all the mapping data pointed to waslb and vav2, so these genes demanded our attention. Mapping implicated these genes, but we still needed to experimentally confirm their role in the flimb phenotype. We used CRISPR-Cas9 to make loss-of-function alleles, but even homozygous null mutants had a wild-type phenotype (Figure 3). Next we tried injecting mutant mRNA into the embryo but saw no effect, likely due to the late appearance of the phenotype. In a final push to demonstrate the causative nature of the waslb and vav2 mutations, we used CRISPR to create frameshift lesions in cis to the candidate mutations and knockout the mutant alleles specifically. When the mutant copies of waslb and vav2 were removed, we rescued the phenotype and reverted the mutants to wild-type fin patterning. There was no doubt, mutations in waslb and vav2 cause the flimb phenotype. But this left us with a bigger question, how in the world are these genes changing skeletal patterning? I came up with an axiom to sooth myself: “if good science raises more questions than it answers, then the best science must raise only questions and answer nothing.”
Figure 3. Rescue experiments demonstrate that a mutation in waslb causes the rephaim phenotype. CRISPR-Cas9 was used to generate null alleles in wild-type and rephaim mutant waslb. Removing wild-type alleles (waslbΔ) had no effect on fin patterning. However, creating a frameshift and early stop upstream of the S265P mutation (waslbΔ+ reph) prevented the formation of intermediate radials and rescued wild-type patterning.
However, the wealth of limb patterning knowledge established by developmental geneticists was able to guide our inquiry. As mentioned earlier, Hox genes have critical functions in the patterning and growth of limb bones along the proximal-distal axis, and recent studies had revealed that Hox13 was required for the formation of the most distal structures in fins just like in limbs (Nakamura et al., 2016). We thought that the new bones in rephaim might also share this distal Hox13 regionality, and crossed rephaim into a Hox13-null genetic background. To our surprise, we found that loss of Hox13 actually enhanced the flimb phenotype and resulted in the formation of even more bones along the distal aspect of the endoskeleton (Figure 4). Hoxa13 is known to negatively regulate Hoxa11 expression in the limb (Kherdjemil et al., 2016), and we thought the enhanced phenotype might be the result of derepression of Hox11 genes. Around this time we also were analyzing limb-specific Wasl knockout mice, and observed limb defects similar to those seen in Hoxa11 mouse mutants. Intriguingly, Hox11 genes are also required for the normal development for the bones in the middle region of the limb, the radius and ulna (Davis et al., 1995).
Figure 4. Genetic interaction between rephaim and Hox genes suggests limb-like patterning mechanisms function in the fin. While loss of hoxa11a, hoxa11b, and hoxd11a has no effect on fin patterning in the wild-type background, removal of these genes prevents the formation of intermediate radials in rephaim mutants. In contrast, removing hoxa13a and hoxa13b from rephaim mutants enhances the phenotype and results in the formation of additional intermediate radials. The requirement of Hox11 genes is shared between intermediate radials and the limb forearm.
Following these clues, we generated null alleles of the hoxa11 and hoxd11 paralogs in the zebrafish. While loss of these genes had no effect on fin patterning in a wild-type background, we found that loss of hoxa11a and hoxa11b prevented the formation of the extra bones in rephaim mutants (Figure 4). Moreover, we generated knock-in hoxa11b reporter zebrafish and found that rephaim and wanda mutants cause the upregulation of hoxa11b expression. These results were quite interesting: even though the Hox11 paralogs are not required for normal fin patterning in zebrafish, they still possess the ability to specify the formation of an intermediate long bone position along the proximal-distal axis of the appendage skeleton. This suggests that the capacity to specify ‘middle’ and ‘distal’ regions is not unique to limbs, but was present in the common ancestor of ray- and lobe-finned fishes. Although not expressed in teleosts, this developmental potential has been retained in a latent state and can be redeployed by simple perturbations.
Wasl, Hox, and Beyond
This forces me to wonder what other latent limb patterning mechanisms that might reside in the developing fin bud, and how waslb is able to activate at least some of them. The mechanistic connection between waslb, vav2, and Hox regulation is an open question. In part, we know that waslb mediates the formation of F-actin foci that colocalize with Hox-positive cells in the distal fin (Hawkins et al., 2021). Given its roles in cell motility it could be that waslb effects the migration of these cells, but there are many other possibilities. Wasl also directly regulates transcription (Wu et al., 2006), modulates Wnt (Lyubimova et al., 2010) and TGFB (Lefever et al., 2010) signaling, and is directly involved in the colinear activation of the HoxB cluster (Ferrai et al., 2009). Then again, there could be another pathway that we do not yet understand. I will go out on a flimb here and say the zebrafish still has more to tell us about these mechanisms…as long as we are willing to trust the mapping.
Arratia, G. (1999). The monophyly of Teleostei and stem-group teleosts. Mesozoic Fishes, 2, 265–334.
Bowen, M. E., Henke, K., Siegfried, K. R., Warman, M. L., & Harris, M. P. (2012). Efficient mapping and cloning of mutations in zebrafish by low-coverage whole-genome sequencing. Genetics, 190(3), 1017–1024.
Capdevila, J., & Izpisúa Belmonte, J. C. (2001). Patterning mechanisms controlling vertebrate limb development. Annual Review of Cell and Developmental Biology, 17, 87–132.
Clack, J. A. (2009). The Fin to Limb Transition: New Data, Interpretations, and Hypotheses from Paleontology and Developmental Biology. Annual Review of Earth and Planetary Sciences, 37(1), 163–179.
Coates, M. I. (1995). Limb evolution. Fish fins or tetrapod limbs–a simple twist of fate? Current Biology: CB, 5(8), 844–848.
Davis, A. P., Witte, D. P., Hsieh-Li, H. M., Potter, S. S., & Capecchi, M. R. (1995). Absence of radius and ulna in mice lacking hoxa-11 and hoxd-11. Nature, 375(6534), 791–795.
Ferrai, C., Naum-Onganía, G., Longobardi, E., Palazzolo, M., Disanza, A., Diaz, V. M., Crippa, M. P., Scita, G., & Blasi, F. (2009). Induction of HoxB transcription by retinoic acid requires actin polymerization. Molecular Biology of the Cell, 20(15), 3543–3551.
Freitas, R., Gómez-Marín, C., Wilson, J. M., Casares, F., & Gómez-Skarmeta, J. L. (2012). Hoxd13 contribution to the evolution of vertebrate appendages. Developmental Cell, 23(6), 1219–1229.
Haffter, P., Odenthal, J., Mullins, M. C., Lin, S., Farrell, M. J., Vogelsang, E., Haas, F., Brand, M., van Eeden, F. J., Furutani-Seiki, M., Granato, M., Hammerschmidt, M., Heisenberg, C. P., Jiang, Y. J., Kane, D. A., Kelsh, R. N., Hopkins, N., & Nüsslein-Volhard, C. (1996). Mutations affecting pigmentation and shape of the adult zebrafish. Development Genes and Evolution, 206(4), 260–276.
Hawkins, M. B., Henke, K., & Harris, M. P. (2021). Latent developmental potential to form limb-like skeletal structures in zebrafish. Cell. https://doi.org/10.1016/j.cell.2021.01.003
Henke, K., Daane, J. M., Hawkins, M. B., Dooley, C. M., Busch-Nentwich, E. M., Stemple, D. L., & Harris, M. P. (2017). Genetic Screen for Postembryonic Development in the Zebrafish (Danio rerio): Dominant Mutations Affecting Adult Form. Genetics, 207(2), 609–623.
Hornstein, I., Alcover, A., & Katzav, S. (2004). Vav proteins, masters of the world of cytoskeleton organization. Cellular Signalling, 16(1), 1–11.
Jessen, H. L. (1972). Fossils and Strata, Schultergurtel und Pectoralflosse bei Actinopterygiern. Lethaia, 5(3), 344.
Kherdjemil, Y., Lalonde, R. L., Sheth, R., Dumouchel, A., de Martino, G., Pineault, K. M., Wellik, D. M., Stadler, H. S., Akimenko, M.-A., & Kmita, M. (2016). Evolution of Hoxa11 regulation in vertebrates is linked to the pentadactyl state. Nature, 539(7627), 89–92.
Knapik, E. W., Goodman, A., Atkinson, O. S., Roberts, C. T., Shiozawa, M., Sim, C. U., Weksler-Zangen, S., Trolliet, M. R., Futrell, C., Innes, B. A., Koike, G., McLaughlin, M. G., Pierre, L., Simon, J. S., Vilallonga, E., Roy, M., Chiang, P. W., Fishman, M. C., Driever, W., & Jacob, H. J. (1996). A reference cross DNA panel for zebrafish (Danio rerio) anchored with simple sequence length polymorphisms. Development , 123, 451–460.
Lefever, T., Pedersen, E., Basse, A., Paus, R., Quondamatteo, F., Stanley, A. C., Langbein, L., Wu, X., Wehland, J., Lommel, S., & Brakebusch, C. (2010). N-WASP is a novel regulator of hair-follicle cycling that controls antiproliferative TGF{beta} pathways. Journal of Cell Science, 123(Pt 1), 128–140.
Lyubimova, A., Garber, J. J., Upadhyay, G., Sharov, A., Anastasoaie, F., Yajnik, V., Cotsarelis, G., Dotto, G. P., Botchkarev, V., & Snapper, S. B. (2010). Neural Wiskott-Aldrich syndrome protein modulates Wnt signaling and is required for hair follicle cycling in mice. The Journal of Clinical Investigation, 120(2), 446–456.
Mercader, N. (2007). Early steps of paired fin development in zebrafish compared with tetrapod limb development. Development, Growth & Differentiation, 49(6), 421–437.
Nakamura, T., Gehrke, A. R., Lemberg, J., Szymaszek, J., & Shubin, N. H. (2016). Digits and fin rays share common developmental histories. Nature, 537(7619), 225–228.
Patton, E. E., & Zon, L. I. (2001). The art and design of genetic screens: zebrafish. Nature Reviews. Genetics, 2(12), 956–966.
Shubin, N. H., Daeschler, E. B., & Jenkins, F. A., Jr. (2006). The pectoral fin of Tiktaalik roseae and the origin of the tetrapod limb. Nature, 440(7085), 764–771.
Snapper, S. B., & Rosen, F. S. (1999). The Wiskott-Aldrich syndrome protein (WASP): roles in signaling and cytoskeletal organization. Annual Review of Immunology, 17, 905–929.
Sordino, P., van der Hoeven, F., & Duboule, D. (1995). Hox gene expression in teleost fins and the origin of vertebrate digits. Nature, 375(6533), 678–681.
van Eeden, F. J., Granato, M., Schach, U., Brand, M., Furutani-Seiki, M., Haffter, P., Hammerschmidt, M., Heisenberg, C. P., Jiang, Y. J., Kane, D. A., Kelsh, R. N., Mullins, M. C., Odenthal, J., Warga, R. M., & Nüsslein-Volhard, C. (1996). Genetic analysis of fin formation in the zebrafish, Danio rerio. Development , 123, 255–262.
Woltering, J. M., Noordermeer, D., Leleu, M., & Duboule, D. (2014). Conservation and divergence of regulatory strategies at Hox Loci and the origin of tetrapod digits. PLoS Biology, 12(1), e1001773.
Wu, X., Yoo, Y., Okuhama, N. N., Tucker, P. W., Liu, G., & Guan, J.-L. (2006). Regulation of RNA-polymerase-II-dependent transcription by N-WASP and its nuclear-binding partners. Nature Cell Biology, 8(7), 756–763.
Zhu, M., & Yu, X. (2009). Stem sarcopterygians have primitive polybasal fin articulation. Biology Letters, 5(3), 372–375.
On Wednesday 14 April Development welcomed three researchers with interests in developmental neurobiology to our seventh Development presents… webinar.
Below you’ll find each of the talks, plus a Q&A chaired by Development Editor François Guillemot. The next #DevPres webinar will be held on 12 May 2021, and chaired by Paola Arlotta – subscribe to our mailing list for updates.
Iva Kelava (LMB Cambridge) – ‘Sex hormones and the human developing brain’
Wael El-Nachef (UCLA) – ‘Schwann cell precursor contribution to the enteric nervous system in post-embryonic zebrafish’
Wael’s paper was published last year in Development (you can also find a link to an interview we did with Wael and Marianne Bronner at the bottom of the abstract)
Stéphane Nedelec (Institut du Fer à Moulin) – ‘Dynamic extrinsic pacing of the HOX clock in human axial progenitors control motor neuron subtype specification’
Stéphane’s paper – featuring co-first authors Vincent Mouilleau and Célia Vaslin – was recently published in Development (you can also find a link to an interview we did with Vincent, Célia and Stéphane at the bottom of the abstract).
Our seventh profile in the series features Dorotea Fracchiolla, who works as a Project Manager in Frankfurt and is also a scientific illustrator.
Where are you originally from and what do you work on now?
I’m originally from Ruvo di Puglia, a town in the province of Bari, Puglia, South Italy. I worked as a Postdoctoral fellow in the field of in vitro reconstitution of Autophagy at the University of Vienna in Austria. In January 2021 I started working at the Max Planck Institute for Biophysics in Frankfurt (Germany) as a Project Manager of an International research collaboration that aims at studying Parkinson’s Disease pathogenesis. In April last year I started my project as a scientific illustrator and founded Art&Science, which gave me the chance to work with many scientists worldwide on art projects in different fields.
Has science always been an important part of your life?
I’ve always been a curious person and with some difficulty in finding THE subject to study. At school I liked everything and was always excited to start reading about new things. In this sense I think I’ve always been a scientist in everyday life. Later on, the actual scientific training provided me with material to feed my curiosity and exercise critical thinking.
And what about art?
Drawing, painting, crafting and trying out new materials were my preferred activities as a child/teenager. Soon enough I started photography, too. All these activities had an aspect in common: sensing. In other words, exploring the world around me, experiencing the new, interacting.
What or who are your artistic influences?
During my studies I have always been attracted by the personality and life of Leonardo da Vinci, an artist and a scientist in one person. As for him, my place of inspiration is Nature. In the beginning, I used to draw things at a macroscopic scale that I had observed while exploring, then I ended up depicting the molecular mechanisms of nano machines like those scientists study in labs. When it comes to style, I think I cannot underplay the influence on me of my place of origin, in its light and bright colors. One example: here in Puglia there is a tradition to make colored clay whistles as local art pieces. Among others, I have recently built a clay model of a set of proteins that participate in the formation of autophagosomes in cells. I think it grossly resembles in style these artcrafts.
How do you make your art?
For me, making art comes after creating an idea in my mind. The creation cannot precede the study and understanding of the subject. I start from reading and while doing so I put together images in my head that finally make up the puzzle. If something is not clear I keep reading until the full picture is completed. My motto is: if you can draw it, you understood it in the first place.
Does your art influence your science at all, or are they separate worlds?
In my opinion, art and science are tightly connected and rely on each other. This is why I named my activity as an illustrator ‘Art&Science’. Very often, while studying a new topic, I tend to first visualize things and make schematics of concepts. Simplification is my approach to understanding. That’s when the art comes into play: it depicts the core message and makes it simple for the eye to grasp.
“Art depicts the core message and makes it simple for the eye to grasp”
Tell us about the work you’ve shared with us.
One project turns around the topic of autophagosome formation. I started drawing these pieces during my PhD when I learnt hardcore biochemistry in the Laboratory of Prof. Sascha Martens at the University of Vienna while studying autophagy in his lab. The entire team was focused on getting recombinant purified components of the autophagy machinery and studying their properties in vitro. The goal was to understand how the different proteins work together to build autophagosomes. Scientific research needs to be coupled to a certain degree of imagination in order for questions to arise. I always liked to visualize things and my preferred way to convey a message is drawing.
Supported by structural biology data, I started off sketching how I thought the molecular machinery looks like, and that’s how the “Autophagosome Biogenesis” project arose.
Clay model, top view
Clay model, top view, close up
Clay model, side view
Clay model, side view 2
Clay model, front view
I first made the drawing and then I created a 3D clay model as shown in the gallery above.
This model was then used as a basis for a stop motion animation (for more information about this movie see my website).
Next is my Ub-p62-cargo illustration: like a sticky sugar muffin that gets stuck in its paper wrap, ubiquitin-tagged misfolded protein aggregates are tightly attached to LC3-positive isolation membranes via p62 during selective autophagy in human cells. I created this for the following publication: https://elifesciences.org/articles/08941
Finally, this gallery shows a lab life series done with acquerells. I created this one during lockdown as well because I was a bit nostalgic for the lab.
What are you thinking of working on next?
Like everyone, I have a dream in the drawer: I would love to illustrate a book, a short collection of recent scientific discoveries made into figures for students. The idea comes not only from the fun I’d have in engaging with such a project but also from my belief that if you make something interesting for students, they will enjoy studying it. At school, drawing things was my way to make things simple for myself – when things are simple it is easier to understand them, and in turn appreciate them.
We’re looking for new people to feature in this series throughout the year – whatever kind of art you do, from sculpture to embroidery to music to drawing, if you want to share it with the community just email thenode@biologists.com (nominations are also welcome!).
We are looking for researchers to participate in the special issue “Maternal-Fetal Crosstalk Impacts on Offspring Development” in Frontiers in Cell and Developmental Biology journal.
In this episode we’re taking a look at the history of gene editing, from the early days of restriction enzymes in the 1960s through to the CRISPR revolution and the very latest base editing techniques.
But while these tools are undeniably powerful and hold great promise for treating disease, with great power comes great responsibility: what are the acceptable limits of genome engineering in humans, and will we see more CRISPRd babies in the future?
If you enjoy the show, please do rate and review on Apple podcasts and help to spread the word on social media. And you can always send feedback and suggestions for future episodes and guests to podcast@geneticsunzipped.com Follow us on Twitter – @geneticsunzip
(No Ratings Yet)
Loading...
